# EDGAR Filing Document

**Accession Number:** 0002067752
**File Stem:** 0002067752-26-000002
**Filing Date:** 2026-5
**Character Count:** 7160
**Document Hash:** b0f66d75c948cdfc0bd18e28e113b75d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002067752-26-000002.hdr.sgml**: 20260519

**ACCESSION NUMBER**: 0002067752-26-000002

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260515

**FILED AS OF DATE**: 20260519

**DATE AS OF CHANGE**: 20260519

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Hansen Ryan P.
- **CENTRAL INDEX KEY:** 0002067752

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41803
- **FILM NUMBER:** 26998878

**MAIL ADDRESS:**
- **STREET 1:** C/O FITLIFE BRANDS, INC.
- **STREET 2:** 5214 S. 136TH STREET
- **CITY:** OMAHA
- **STATE:** NE
- **ZIP:** 68137
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FITLIFE BRANDS, INC.
- **CENTRAL INDEX KEY:** 0001374328
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 5214 S. 136TH STREET
- **CITY:** OMAHA
- **STATE:** NE
- **ZIP:** 68137
- **BUSINESS PHONE:** 402-884-1894

**MAIL ADDRESS:**
- **STREET 1:** 5214 S. 136TH STREET
- **CITY:** OMAHA
- **STATE:** NE
- **ZIP:** 68137

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BOND LABORATORIES, INC.
- **DATE OF NAME CHANGE:** 20060831

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Hansen Ryan P.<br><sub>(Last) (First) (Middle)</sub><br>C/O FITLIFE BRANDS, INC.<br>5214 S. 13TH STREET<br><sub>(Street)</sub><br>OMAHA, NE 68137<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-05-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>FITLIFE BRANDS, INC. [ FTLF ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Options | $10.50 | 2026-05-15 |  | A |  | 28500<sup>(1)</sup> |  | <sup>(2)</sup> | 2031-05-15 | Common Stock | 28500 | <sup>(1)</sup> | 28500 | D |  |
| Stock Options | $10.50 | 2026-05-15 |  | A |  | 46500<sup>(3)</sup> |  | <sup>(2)</sup> | 2031-05-15 | Common Stock | 46500 | <sup>(3)</sup> | 75000 | D |  |
| Performance Stock Units | <sup>(4)</sup> | 2026-05-15 |  | A |  | 50000<sup>(4)</sup> |  | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 50000 | <sup>(4)</sup> | 125000 | D |  |

---

### Footnotes:

(1) Represents incentive stock options granted in connection with the Reporting Person's appointment as President, issued pursuant to the Issuer's 2019 Omnibus Incentive Plan.

(2) One-third (1/3) of the stock options vest on the one-year anniversary of the grant date, with the remainder vesting in equal increments on each of the second and third anniversary thereafter, subject to continued service.

(3) Represents non-qualified stock options granted in connection with the Reporting Person's appointment as President, issued pursuant to the Issuer's 2019 Omnibus Incentive Plan.

(4) Represents performance stock units ("PSUs") granted in connection with the Reporting Person's appointment as President, issued pursuant to the Issuer's 2019 Omnibus Equity Incentive Plan. Each PSU represents a contingent right to receive one share of the Issuer's common stock upon vesting, subject to continued service. The PSU will vest on such date that the 30 day volume weighted average price ("VWAP") for shares of the Issuer's common stock meets or exceeds $20.00, and expire on the fifth anniversary of the grant date if not then vested.

**Signature:** /s/ Ryan Hansen  
**Date:** 2026-05-19

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**